WEST PHARMACEUTICAL SERVICES, INC. Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) of $32.70 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-27.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperations · last filed 2013-02-27
- WEST PHARMACEUTICAL SERVICES, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2012 was $32.70M, a 39.15% increase from fiscal 2011.
- WEST PHARMACEUTICAL SERVICES, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2011 was $23.50M, a 72.79% increase from fiscal 2010.
- WEST PHARMACEUTICAL SERVICES, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2010 was $13.60M.
| Period end | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-12-31 | $32.70M 10-K · filed 2013-02-27 |
| 2011-12-31 | $23.50M 10-K · filed 2013-02-27 |
| 2010-12-31 | $13.60M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |